COMBINATION OF METFORMIN R-(+)-LIPOATE AND ANTIOBESITY AGENTS FOR THE TREATMENT OF DIABETIC HYPERGLYCEMIA AND DIABETIC COMPLICATIONS

摘要

Disclosed are pharmaceutical compositions, methods of treatment, and kits for the treatment of Type 2 diabetic hyperglycemia and diabetic complications using combination treatments comprising metformin R-(+)-lipoate and antiobesity agents.